CellBios® is specialized in cell-based therapies and biotechnology, playing a significant role in a variety of advanced therapies, including stem cell therapy, T cell therapy, CAR-T cell therapy, dendritic cell therapy, autologous and allogeneic gene therapy, regenerative medicine, gene therapy vector delivery, tissue engineering, and 3D bioprinting. Our products and services are crucial for the progression of these fields wherein we provide the tools, technologies, and expertise to improve outcomes and address specific challenges. Here&’s how Cellbios® products impact each of these therapies:

Large-scale production of biologics like monoclonal antibodies, mRNA vaccines, viral vectors, and biosimilars relies on sophisticated bioprocessing techniques to guarantee safety, efficacy, and sufficient supply.  Each of these biologics has unique manufacturing requirements, spanning cell culture and genetic engineering to purification, formulation, and sterile fill-finish. CellBios provides a complete suite of bioprocessing solutions, including bioreactors, freeze-thaw systems, cell culture bags, and sterile biocontainers, to support all phases of biologic production.  Using these advanced technologies, manufacturers can streamline their processes, preserve product stability, and achieve cost-effective scalability, ultimately providing patients worldwide with access to high-quality biotherapeutics.

CellBios® is specialized in cell-based therapies and biotechnology, playing a significant role in a variety of advanced therapies, including stem cell therapy, T cell therapy, CAR-T cell therapy, dendritic cell therapy, autologous and allogeneic gene therapy, regenerative medicine, gene therapy vector delivery, tissue engineering, and 3D bioprinting. Our products and services are crucial for the progression of these fields wherein we provide the tools, technologies, and expertise to improve outcomes and address specific challenges. Here&’s how Cellbios® products impact each of these therapies: